Horizon Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.34M | Buy |
42,478
+22,417
| +112% | +$1.21M | 0.03% | 443 |
|
|
2025
Q4 | $984K | Buy |
20,061
+1,082
| +6% | +$50.5K | 0.01% | 639 |
|
|
2025
Q3 | $819K | Buy |
18,979
+1,387
| +8% | +$54.2K | 0.01% | 674 |
|
|
2025
Q2 | $676K | Buy |
17,592
+640
| +4% | +$24.5K | 0.01% | 667 |
|
|
2025
Q1 | $657K | Sell |
16,952
-254
| -1% | -$9.3K | 0.02% | 335 |
|
|
2024
Q4 | $582K | Buy |
17,206
+455
| +3% | +$16.4K | 0.02% | 341 |
|
|
2024
Q3 | $685K | Sell |
16,751
-109
| -0.6% | -$4.46K | 0.02% | 311 |
|
|
2024
Q2 | $649K | Sell |
16,860
-181
| -1% | -$7.61K | 0.02% | 323 |
|
|
2024
Q1 | $731K | Buy |
17,041
+17,024
| +100,141% | +$702K | 0.02% | 297 |
|
|
2023
Q4 | $630 | Buy |
+17
| New | +$610 | ﹤0.01% | 701 |
|
|
2022
Q3 | – | Sell |
-18,104
| Closed | -$1M | – | 502 |
|
|
2022
Q2 | $1M | Buy |
+18,104
| New | +$999K | 0.03% | 180 |
|
|
2021
Q3 | – | Sell |
-26,942
| Closed | -$1.34M | – | 492 |
|
|
2021
Q2 | $1.34M | Sell |
26,942
-10,062
| -27% | -$483K | 0.04% | 180 |
|
|
2021
Q1 | $1.65M | Buy |
+37,004
| New | +$1.68M | 0.06% | 144 |
|
|
2020
Q4 | – | Sell |
-22,427
| Closed | -$1.04M | – | 214 |
|
|
2020
Q3 | $1.04M | Buy |
22,427
+10,583
| +89% | +$530K | 0.04% | 178 |
|
|
2020
Q2 | $597K | Sell |
11,844
-22
| -0.2% | -$1.13K | 0.01% | 309 |
|
|
2020
Q1 | $556K | Sell |
11,866
-87,885
| -88% | -$4.69M | 0.03% | 172 |
|
|
2019
Q4 | $5.86M | Buy |
99,751
+20,057
| +25% | +$1.12M | 0.26% | 55 |
|
|
2019
Q3 | $4.21M | Sell |
79,694
-1,304
| -2% | -$67.1K | 0.17% | 64 |
|
|
2019
Q2 | $4.05M | Buy |
80,998
+29,572
| +58% | +$1.48M | 0.11% | 55 |
|
|
2019
Q1 | $2.65M | Buy |
51,426
+37,541
| +270% | +$1.88M | 0.09% | 110 |
|
|
2018
Q4 | $663K | Sell |
13,885
-666
| -5% | -$32.8K | 0.03% | 164 |
|
|
2018
Q3 | $731K | Sell |
14,551
-17
| -0.1% | -$864 | 0.02% | 171 |
|
|
2018
Q2 | $725K | Sell |
14,568
-22,842
| -61% | -$1.15M | 0.03% | 163 |
|
|
2018
Q1 | $1.83M | Buy |
37,410
+9,979
| +36% | +$465K | 0.08% | 75 |
|
|
2017
Q4 | $1.48M | Buy |
+27,431
| New | +$1.27M | 0.09% | 69 |
|
|
2017
Q1 | – | Sell |
-13,859
| Closed | -$667K | – | 178 |
|
|
2016
Q4 | $667K | Sell |
13,859
-117
| -0.8% | -$5.78K | 0.05% | 85 |
|
|
2016
Q3 | $753K | Sell |
13,976
-54,420
| -80% | -$2.98M | 0.05% | 57 |
|
|
2016
Q2 | $3.71M | Sell |
68,396
-466
| -0.7% | -$24.5K | 0.28% | 34 |
|
|
2016
Q1 | $3.49M | Buy |
+68,862
| New | +$3.43M | 0.28% | 32 |
|
|
2014
Q2 | – | Sell |
-25,505
| Closed | -$1.7M | – | 116 |
|
|
2014
Q1 | $1.7M | Buy |
25,505
+4,467
| +21% | +$302K | 0.22% | 44 |
|
|
2013
Q4 | $1.4M | Buy |
21,038
+4,112
| +24% | +$267K | 0.21% | 27 |
|
|
2013
Q3 | $1.06M | Buy |
16,926
+4,626
| +38% | +$298K | 0.25% | 25 |
|
|
2013
Q2 | $768K | Buy |
+12,300
| New | +$781K | 0.22% | 23 |
|
Other funds holding GSK
JEST
Horizon Investments's GSK Position: Q1 2026 in Review
Horizon Investments increased its GSK (GSK) stake by 112% in Q1 2026, buying an estimated $1.21M and bringing the position to 42,478 shares worth $2.34M. The position accounts for 0.03% of the portfolio, ranked #443.
Horizon Investments first reported a position in GSK in Q2 2013 and has held it in 33 quarters since. The position peaked at $5.86M in Q4 2019. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Horizon Investments held 42,478 shares of GSK worth $2.34M as of Q1 2026.
- Horizon Investments bought 22,417 GSK shares in Q1 2026, an estimated $1.21M.
- GSK made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #443 holding.
- Horizon Investments first reported a position in GSK in Q2 2013 and has held it in 33 quarters since.
- Horizon Investments's GSK position peaked at $5.86M in Q4 2019.
- 1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.